Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

counterfeit medicines

INC Research expands Asian presence with South Korea facility

New Seoul office will focus on study start-up and clinical operations

- PMLiVE

UCB opens biotech plant in Belgium

100 jobs created as pharma firm plans to expand its focus on biologics

- PMLiVE

Takeda completes new manufacturing facility in Russia

Expands Japanese firm’s presence in key emerging market

- PMLiVE

Merck KGaA acquires cancer drug from Symphogen

Will pay up to €495m for investigational metastatic colorectal cancer treatment

- PMLiVE

US drug approval numbers fall despite pharma investing more in R&D

Stricter FDA policies are partly to blame for the decline says GBI Research

- PMLiVE

Merck KGaA plans to cut 1,100 jobs in Germany

Production also halted at two German facilities

- PMLiVE

BIA says crowdfunding scheme could ‘create 1,500 jobs a year’

Wants UK tax concessions for individuals who invest

- PMLiVE

Merck Serono spins off biomarker specialist

Led by Jérôme Wojcik, Quartz Bio will operate as a contract research organisation

- PMLiVE

Interview: Stephan Tanda, EuropaBio

The chairman of EuropaBio explains to Linda Banks how he believes accelerating uptake of biotechnologies can address European and world challenges

- PMLiVE

Interview with Andrea Rappagliosi, EuropaBio

The chairman of EuropaBio talks to editor of PME Linda Banks about how biotechnology influences understanding of diseases and the development of new drugs

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links